More than 7 million Americans struggle with essential tremor (ET), but only one in 10 ET patients is satisfied with their current treatment. Cala Health — a San Mateo, California-based bioelectronic ...

SAN MATEO, Calif. and CHICAGO, April 15, 2026 /PRNewswire/ -- Cala ®, the bioelectronic medicine leader, today announced U.S. Food and Drug Administration (FDA) clearance of the Cala kIQ ® Plus system ...

The Food and Drug Administration approved the Exablate Neuro system as the first focused ultrasound device intended to treat essential tremor in patients who do not respond to conventional medication.

Please provide your email address to receive an email when new articles are posted on . A Bay Area bioelectronic medicine company announced the commercial launch of its next-generation Cala kIQ System ...

The funds from Trinity Capital are expected to advance commercialisation efforts for Cala Health’s device for alleviating ...

388813 01: A photo illustration depicts a person typing May 4, 2001 in Denver, CO. National Academy of Sciences estimates that musculoskeletal disorders such as carpal-tunnel syndrome, tendinitis, and ...

--Wristband is a first-of-its-kind investigational wearable designed to provide dynamic, all-day, personalized relief for people with essential tremor (ET); powered by advanced AI to continuously ...

The FDA cleared an artificial intelligence (AI)-powered wristband (Felix NeuroAI) to treat upper-limb functional limitations in adults with essential tremor, device maker Fasikl announced. The ...

Essential tremor is one of the most common movement disorders, yet it often is mistaken for other neurological conditions such as Parkinson’s disease. Affecting an estimated 7 to 10 million Americans, ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...